Thu, Nov 27, 2014, 10:13 PM EST - U.S. Markets closed for Thanksgiving Day


% | $
Quotes you view appear here for quick access.

Prima Biomed Ltd. Message Board

  • drivrb drivrb Oct 18, 2012 2:23 PM Flag

    Business Summary

    Prima BioMed Ltd, a biotechnology company, engages in the research and commercialization of licensed medical biotechnology products in Australia. It develops oncology therapies in the field of immunotherapy. The company’s lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. It also manufactures mannosylated fusion protein, a critical component to CVac that contains the antigen necessary for the dendritic cells to illicit an immune response against tumor cells. In addition, the company focuses on developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd is based in Sydney, Australia.

0.94-0.0386(-3.94%)Nov 26 11:30 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Infoblox Inc.
NYSEWed, Nov 26, 2014 4:01 PM EST